WNT pathway members, FZD7 (C3), WNT6 (C4), WNT11 (C5) and FZD9 (4) were all preferentially expressed in basal-like tumors suggesting novel therapeutic opportunities for basal-like breast cancer brain metastases. Here, FZD7 is linked to breast carcinoma.